Skip to Content

RL 13 (Erlotinib 150 mg)

Pill with imprint RL 13 is White, Round and has been identified as Erlotinib 150 mg. It is supplied by Sun Pharmaceutical Industries Inc..

Erlotinib is used in the treatment of non-small cell lung cancer; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Erlotinib 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RL 13

Erlotinib

Imprint
RL 13
Strength
150 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
EGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sun Pharmaceutical Industries Inc.
National Drug Code (NDC)
63304-0135

Get help with Imprint Code FAQs.

Related Images for "RL 13"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.